The United States Government is proud to work in partnership with governments and institutions in
Since the beginning of the
Investing in the health workforce to build more resilient health systems
In
As part of the GHWI, the Administration plans to work with
Initiatives in support of this regional health workforce commitment include:
USAID recently launched its Accelerating Primary Health Care Collaborative (APHC-C), which aims to work with partner countries inAfrica to accelerate primary health care to reclaim lost ground on global health and to foster resilience and preparedness against future threats. These efforts will focus on an initial set of five partner countries, Côte d'Ivoire,Ghana ,Kenya ,Malawi , andNigeria , harnessing theUSAID and PMI health footprint, supported by an average of over$415 million annually inUSAID funds in 2022 and 2023.- Strengthening HIV/AIDS Health Worker Leadership in Global Health through PEPFAR. To advance
Africa's commitment to increase and retain health care workers, PEPFAR is committed to investing approximately$1.1 billion annually to support the more than 325,000 health workers in the regionwho enable the delivery of HIV/AIDS programs. The support for this health workforce will not only protect and scale HIV gains, but can also be leveraged to fight outbreaks and other disease threats.
- The
U.S. President's Malaria Initiative (PMI) is working across the health system in 24 countries inAfrica to deepen our support for the health workforce, including by enacting a policy change in 2021 to catalyze long-term investment in community health workers with access to the hardest-to-reach areas affected by malaria. Under this new policy, partner countries throughoutAfrica are paying community health workers with PMI funds. - The
Centers for Disease Control and Prevention (CDC ) is continuing to invest in health workforce programs throughout the region, including through: - Support for Africa
CDC through the NationalPublic Health Institute (NPHI) Program, which offers ongoing trainings and directs technical assistance that strengthen the capacity of AfricaCDC staff in surveillance methodologies and disease prevention and control. Since the beginning of the Administration, with current and planned investments of at least$9.7 million ,CDC is supporting AfricaCDC to build out an online platform for supporting AfricaCDC 's goals of building workforce capacity withinAfrican Union Member States. - The Field Epidemiology Training Program (FETP), with
$47 million in invested and plannedCDC funding since Fiscal Year 2021, strengthens countries' capacity to prevent, detect, and respond to public health threats. FETP graduates were mobilized during recent outbreaks of Rift Valley Fever and Crimean-Congo hemorrhagic fever inMauritania , Sudan Ebolavirus inUganda , and the 2021 Ebola outbreak inGuinea , as well as the COVID-19 response in multiple countries. - The Global Laboratory Leadership Program (GLLP), with
$5.2 million in invested and plannedCDC support since Fiscal Year 2021, mentors current and emerging laboratory leaders to build, strengthen, and sustain national laboratory systems with aOne Health focus.
Partnering to build stronger health systems and strengthen global health security
- Partnership to accelerate regional manufacturing. PEPFAR and PMI continue to leverage their platforms in the region to accelerate regional manufacturing capacity:
- PEPFAR currently spends roughly
$750 million in the purchase of HIV-related commodities every year, but less than 1 percent of that total is used to procure commodities from African manufacturers. PEPFAR is actively exploring opportunities to shift its procurement practices to spur growth in the regional manufacturing ecosystem. Building on existing capabilities and an analysis of future expansion potential: for HIV rapid diagnostics, by 2025, PEPFAR aims to procure 15 million tests produced by African manufacturers at an estimated cost of$20 million . For ARVs, by 2030, PEPFAR aims to work alongside other partners and buyers to shift at least two million patients on first-line ARV treatments to use African-made products. DFC also seeks to finance eligible private sector projects that build regional manufacturing capacity for therapeutics, diagnostics, and ancillary supplies in developing countries, with a focus onAfrica . - PMI is committed to building a more resilient supply chain and is leveraging its procurement volume to accelerate the growth in regional manufacturing. The inclusion of evaluation criteria in recent tenders related to manufacturing on the continent led to an estimated 30 percent of PMI's 2023 standard mosquito net procurement being sourced from African-based manufacturers.
- Senegal
Institut Pasteur deDakar (IPD) Flexible Vaccine Manufacturing Facility. TheU.S. International Development Finance Corporation (DFC), along withInternational Finance Corporation (IFC) and other like-minded development finance institutions, is continuing to support IPD inSenegal to become a key hub in theAfrican Union's vaccine production network. DFC previously provided a$3.3 million technical assistance grant for early-stage project development and is evaluating additional financing for expansion of the industrial-scale facility. - Harnessing Data Science for
Health Discovery and Innovation inAfrica (DS-I Africa) was established in 2021, and since the beginning of the Administration NIH has invested$49 million since the beginning of the Administration to leverage data science technologies to develop solutions to the continent's most pressing public health problems. NIH is expanding DS-I Africa through new educational activities that enhance workforce training to meet the biomedical, behavioral and clinical needs. - The STOP Program (STOP), which has been active in nearly every African country over the life of the program, is a collaboration between
CDC ,WHO , andUNICEF to strengthen national immunization surveillance programs, support supplemental immunization activities, respond to disease outbreaks, and help support polio eradication. Since the beginning of the Administration,CDC has committed and aims to invest at least$32.1 million .
Investing in Health Infrastructure
G7 leaders launched the
- DFC and
USAID announced their collaboration with theTransform Health Fund , an innovative blended-finance fund focused on locally-led health supply chain, care delivery, and digital solutions inAfrica . DFC andUSAID will finalize$10 million in equity financing and$1 million in catalytic grant funding, respectively. With these investments, the Fund announced approved commitments of$50 million . The majority women-led fund is a collaborative effort bringing together government, donor, and commercial investments under the leadership of AfricInvest and theHealth Finance Coalition to finance enterprises that improve health system resilience and pandemic preparedness across the continent. The Fund will also promote women in leadership positions across its pipeline and target female consumers while ensuring that at least 30% of its portfolio is aligned with 2X criteria, DFCs flagship program to support women's economic empowerment in emerging markets. - Power
Africa announced theHealthcare Electrification and Telecommunication Alliance (HETA), with$10 million in funding, a$150 million partnership program to power up and digitally connect thousands of health facilities in sub-Saharan Africa, transforming them into hubs of clean energy development.
- DFC committed a
$10 million equity investment equivalent to theWater Access Acceleration Fund (W2AF). W2AF is a E50 million blended finance fund, accompanied by a E2.5 million technical assistance facility. The fund will invest in approximately 10 small and medium-sized enterprises in the water, sanitation, and hygiene sector to scale access to potable and affordable water in sub-Saharan Africa and other emerging markets. W2AF also has strong support fromUSAID with their commitment of$1.1 million for technical assistance and first loss. - USTDA has announced a series of health system investments in
Nigeria totaling$3 million , including a feasibility study for the Nigerian private healthcare networkLily Hospitals Limited to support the acquisition, refurbishment, and operation of ten healthcare facilities inNigeria ; a feasibility study for the expansion of healthcare and related-sector logistics using unmanned aerial vehicles; and a feasibility study forCedarcrest Hospitals Limited , a Nigerian private health operator, to support the development of a comprehensive cancer treatment center inAbuja, Nigeria .
Partnering on Cancer Prevention, Detection, Treatment and Research
Copyright The White House. Distributed by AllAfrica Global Media (allAfrica.com)., source